Orchestra BioMed Holdings, Inc.

$5.55- (-)1Y +43.95%

As of Oct 26, 2026 close

Market cap: $354.16M
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $3.46$6.50
Volume (live): -
Avg. volume (3M): 343.41K

Orchestra BioMed Holdings, Inc. (OBIO) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Orchestra BioMed Holdings, Inc. stock.

Analyst Consensus Rating

Investment consensus from 6 professional research analysts

Consensus Rating

Buy

Based on 6 unique analysts

(8 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$11.60

+109.01% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest OBIO Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 15, 2026	Matthew O'Brien	Piper Sandler	Maintains	Buy	$10.00 → $12.00 +2.00 (+20.0%)
Oct 5, 2026	Yi Chen	HC Wainwright	Reiterates	Buy	$10.00
Oct 2, 2026	Yi Chen	HC Wainwright	Reiterates	Buy	$10.00
Oct 2, 2026	Madison Elsaadi	B Riley	Reiterates	Buy	$11.00
Sep 25, 2026	Josh Jennings	TD Cowen	Reiterates	Buy	$15.00
Sep 21, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Hold	-
Sep 10, 2026	Marie Thibault	BTIG	Upgrades	Buy	$10.00
Aug 11, 2026	Matthew O'Brien	Piper Sandler	Reiterates	Buy	$9.00 → $10.00 +1.00 (+11.1%)

Matthew O'Brien

Piper Sandler

BuyMaintains

$10.00 → $12.00

Oct 15

Yi Chen

HC Wainwright

BuyReiterates

$10.00

Oct 5

Yi Chen

HC Wainwright

BuyReiterates

$10.00

Oct 2

Madison Elsaadi

B Riley

BuyReiterates

$11.00

Oct 2

Josh Jennings

TD Cowen

BuyReiterates

$15.00

Sep 25

Zacks Equity Research

HoldInitiates Coverage

Sep 21

Marie Thibault

BTIG

BuyUpgrades

$10.00

Sep 10

Matthew O'Brien

Piper Sandler

BuyReiterates

$9.00 → $10.00

Aug 11

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 15, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for OBIO?

The analyst consensus rating for OBIO is Buy, based on the latest ratings from 6 analysts over the last 90 days.

What is the average price target for OBIO?

The average 12-month price target for OBIO is $11.60, representing an upside of 109.0% from the Oct 26, 2026 close of $5.55.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.